Novel A,B,E-Ring-Modified Camptothecins Displaying High Lipophilicity and Markedly Improved Human Blood Stabilities
Open Access
- 22 July 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (16), 3018-3022
- https://doi.org/10.1021/jm9902279
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Homocamptothecins: Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin AnaloguesJournal of Medicinal Chemistry, 1998
- A General Synthetic Approach to the (20S)-Camptothecin Family of Antitumor Agents by a Regiocontrolled Cascade Radical Cyclization of Aryl IsonitrilesChemistry – A European Journal, 1998
- BN 80245: An E-ring modified camptothecin with potent antiproliferative and topoisomerase I inhibitory activitiesBioorganic & Medicinal Chemistry Letters, 1997
- The Important Role of Albumin in Determining the Relative Human Blood Stabilities of the Camptothecin Anticancer DrugsJournal of Pharmaceutical Sciences, 1995
- Preferential Binding of the Carboxylate Form of Camptothecin by Human Serum AlbuminAnalytical Biochemistry, 1993
- The Current Status of Camptothecin Analogues as Antitumor AgentsJNCI Journal of the National Cancer Institute, 1993
- Geometry and dynamics of benzene chemisorbed on a platinum/.eta.-alumina catalyst: a carbon-13 dipolar NMR studyJournal of the American Chemical Society, 1992
- A kinetic and Mechanistic Study of the Hydrolysis of Camptothecin and Some AnaloguesJournal of Pharmaceutical Sciences, 1992
- DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in XenograftsScience, 1989
- On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complexBiochemistry, 1989